Detrimental effects of secondhand smoke exposure on infants with cystic fibrosis

Pediatric Pulmonology

Volumn 50, Issue 1, 2015, Pages 25-34

  Kopp, Benjamin T ^a   Sarzynski, Lisa ^a   Khalfoun, Sabrina ^a   Hayes, Don ^a   Thompson, Rohan ^a   Nicholson, Lisa ^b   Long, Frederick ^a   Castile, Robert ^a   Groner, Judith ^a  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

MRSA; Nutrition; Pulmonary function testing; Tobacco

Indexed keywords

SALBUTAMOL; BRONCHODILATING AGENT; PASSIVE SMOKING;

ANAEROBIC BACTERIUM; ANAEROBIC GROWTH; BACTERIUM CULTURE; BRONCHODILATATION; CHILD GROWTH; CHILD HOSPITALIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTROLLED STUDY; CYSTIC FIBROSIS; EXPOSURE; FEMALE; HUMAN; INFANT; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PARENTAL SMOKING; PASSIVE SMOKING; PRIORITY JOURNAL; SMOKING CESSATION; ADVERSE EFFECTS; AIR; COMPLICATION; DRUG TOLERANCE; GROWTH DISORDERS; ISOLATION AND PURIFICATION; LUNG; MICROBIOLOGY; RADIOGRAPHY; RETROSPECTIVE STUDY; SPUTUM;

AIR; BRONCHODILATOR AGENTS; CYSTIC FIBROSIS; DRUG TOLERANCE; FEMALE; GROWTH DISORDERS; HUMANS; INFANT; LUNG; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; RETROSPECTIVE STUDIES; SPUTUM; TOBACCO SMOKE POLLUTION;

EID: 84922723245     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.23016     Document Type: Conference Paper

References (42)

1. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR, Smith AE. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-834.
2. Gregory RJ, Cheng SH, Rich DP, Marshall J, Paul S, Hehir K, Ostedgaard L, Klinger KW, Welsh MJ, Smith AE. Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature 1990;347:382-386.
3. Rich DP, Anderson MP, Gregory RJ, Cheng SH, Paul S, Jefferson DM, McCann JD, Klinger KW, Smith AE, Welsh MJ. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature 1990;347:358-363.
4. Parsons HG, Beaudry P, Dumas A, Pencharz PB. Energy needs and growth in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 1983;2:44-49.
5. Ranganathan SC, Parsons F, Gangell C, Brennan S, Stick SM, Sly PD. Evolution of pulmonary inflammation and nutritional status in infants and young children with cystic fibrosis. Thorax 2011;66: 408-413.
6. Brady H, Lamb MM, Sokol RJ, Ross CA, Seifert JA, Rewers MJ, Norris JM. Plasma micronutrients are associated with dietary intake and environmental tobacco smoke exposure in a paediatric population. Public Health Nutr 2007;10:712-718.
7. Cantin AM, Hanrahan JW, Bilodeau G, Ellis L, Dupuis A, Liao J, Zielenski J, Durie P. Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers. Am J Respir Crit Care Med 2006;173:1139-1144.
8. Sloane PA, Shastry S, Wilhelm A, Courville C, Tang LP, Backer K, Levin E, Raju SV, Li Y, Mazur M, Byan-Parker S, Grizzle W, Sorscher EJ, Dransfield MT, Rowe SM. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. PLoS ONE 2012;7:e39809.
9. Rosenfeld M, Emerson J, McNamara S, Joubran K, Retsch-Bogart G, Graff GR, Gutierrez HH, Kanga JF, Lahiri T, Noyes B, Ramsey B, Ren CL, Schechter M, Morgan W, Gibson RL. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort. Pediatr Pulmonol 2010;45:934-944.
10. Fulkerson JA, French SA. Cigarette smoking for weight loss or control among adolescents: gender and racial/ethnic differences. J Adolesc Health 2003;32:306-313.
11. Goncalves-Silva RM, Valente JG, Lemos-Santos MG, Sichieri R. [Household smoking and stunting for children under five years]. Cad Saude Publica 2005;21:1540-1549.
12. Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med 1990;323:782-788.
13. Collaco JM, Vanscoy L, Bremer L, McDougal K, Blackman SM, Bowers A, Naughton K, Jennings J, Ellen J, Cutting GR. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA 2008;299:417-424.
14. Ren CL, Rosenfeld M, Mayer OH, Davis SD, Kloster M, Castile RG, Hiatt PW, Hart M, Johnson R, Jones P, Brumback LC, Kerby GS. Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis. Pediatr Pulmonol 2012;47:574-581.
15. Rosenfeld M, Farrell PM, Kloster M, Swanson JO, Vu T, Brumback L, Acton JD, Castile RG, Colin AA, Conrad CK, Hart MA, Kerby GS, Hiatt PW, Mogayzel PJ, Johnson RC, Davis SD. Association of lung function, Chest radiographs and clinical features in infants with cystic fibrosis. Eur Respir J 2013;42:1545-1552.
16. Cystic Fibrosis Foundation Patient Registry. 2011; Annual Data Report. Bethesda, Maryland. 2012 Cystic Fibrosis Foundation 2011.
17. Campbell PW, III, Parker RA, Roberts BT, Krishnamani MR, Phillips JA, III. Association of poor clinical status and heavy exposure to tobacco smoke in patients with cystic fibrosis who are homozygous for the F508 deletion. J Pediatr 1992;120:261-264.
18. Risks of smoking for people with CF. Cystic Fibrosis Foundation; 2013.
19. Kohler E, Sollich V, Schuster R, Thal W. Passive smoke exposure in infants and children with respiratory tract diseases. Hum Exp Toxicol 1999;18:212-217.
20. Waters DL, Wilcken B, Irwing L, Van Asperen P, Mellis C, Simpson JM, Brown J, Gaskin KJ. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Edn 1999;80:F1-F7.
21. Padman R, McColley SA, Miller DP, Konstan MW, Morgan WJ, Schechter MS, Ren CL, Wagener JS. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function. Pediatrics 2007;119:e531-e537.
22. Rosenfeld M. Overview of published evidence on outcomes with early diagnosis from large US observational studies. J Pediatr 2005;147:S11-S14.
23. Davis SD, Rosenfeld M, Kerby GS, Brumback L, Kloster MH, Acton JD, Colin AA, Conrad CK, Hart MA, Hiatt PW, Mogayzel PJ, Johnson RC, Wilcox SL, Castile RG. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010;182:1387-1397.
24. Jones M, Castile R, Davis S, Kisling J, Filbrun D, Flucke R, Goldstein A, Emsley C, Ambrosius W, Tepper RS. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med 2000;161:353-359.
25. Castile R, Filbrun D, Flucke R, Franklin W, McCoy K. Adult-type pulmonary function tests in infants without respiratory disease. Pediatr Pulmonol 2000;30:215-227.
26. Brody AS, Tiddens HA, Castile RG, Coxson HO, de Jong PA, Goldin J, Huda W, Long FR, McNitt-Gray M, Rock M, Robinson TE, Sagel SD. Computed tomography in the evaluation of cystic fibrosis lung disease. Am J Respir Crit Care Med 2005;172:1246-1252.
27. Raju SV, Jackson PL, Courville CA, McNicholas CM, Sloane PA, Sabbatini G, Tidwell S, Tang LP, Liu B, Fortenberry JA, Jones CW, Boydston JA, Clancy JP, Bowen L, Accurso FJ, Blalock JE, Dransfield MT, Rowe SM. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator (CFTR) function. Am J Respir Crit Care Med 2013;188:1321-1330.
28. Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, Gaggar A, Steele C, Tang LP, Liu B, Rowe SM. Acquired cystic fibrosis transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest 2013;144:498-506.
29. Hassan F, Nuovo GJ, Crawford M, Boyaka PN, Kirkby S, Nana-Sinkam SP, Cormet-Boyaka E.MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. PLoS ONE 2012;7:e50837.
30. Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, Bennett WD, Riordan JR, Boucher RC, Tarran R. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J 2012;26:533-545.
31. Southern KW, Merelle MM, Dankert-Roelse JE, Nagelkerke AD. Newborn screening for cystic fibrosis. Cochrane Database Syst Rev 2009; CD001402.
32. Kovesi T, Corey M, Levison H. Passive smoking and lung function in cystic fibrosis. Am Rev Respir Dis 1993;148:1266-1271.
33. Arjomandi M, Haight T, Redberg R, Gold WM. Pulmonary function abnormalities in never-smoking flight attendants exposed to secondhand tobacco smoke in the aircraft cabin. J Occup Environ Med 2009;51:639-646.
34. Ortega-Garcia JA, Lopez-Fernandez MT, Llano R, Pastor-Vivero MD, Mondejar-Lopez P, Sanchez-Sauco MF, Sanchez-Solis M. Smoking prevention and cessation programme in cystic fibrosis: integrating an environmental health approach. J Cyst Fibros 2012;11:34-39.
35. Bakker EM, Borsboom GJ, van der Wiel-Kooij EC, Caudri D, Rosenfeld M, Tiddens HA. Small airway involvement in cystic fibrosis lung disease: routine spirometry as an early and sensitive marker. Pediatr Pulmonol 2013;48:1081-1088.
36. Greene CM, Ramsay H, Wells RJ, O'Neill SJ, McElvaney NG. Inhibition of Toll-like receptor 2-mediated interleukin-8 production in Cystic Fibrosis airway epithelial cells via the alpha7-nicotinic acetylcholine receptor. Mediat Inflam 2010;2010: 423241.
37. Tebow G, Sherrill DL, Lohman IC, Stern DA, Wright AL, Martinez FD, Halonen M, Guerra S. Effects of parental smoking on interferon gamma production in children. Pediatrics 2008;121: e1563-e1569.
38. Matsuzawa T, Kim BH, Shenoy AR, Kamitani S, Miyake M, Macmicking JD. IFN-gamma elicits macrophage autophagy via the p38 MAPK signaling pathway. J Immunol 2012;189:813-818.
39. Smyth A, O'Hea U, Feyerabend C, Lewis S, Smyth R. Trends in passive smoking in cystic fibrosis, 1993-1998. Pediatr Pulmonol 2001;31:133-137.
40. Smyth A, O'Hea U, Williams G, Smyth R, Heaf D. Passive smoking and impaired lung function in cystic fibrosis. Arch Dis Child 1994;71:353-354.
41. Ranganathan SC, Dezateux C, Bush A, Carr SB, Castle RA, Madge S, Price J, Stroobant J, Wade A, Wallis C, Stocks J. Airway function in infants newly diagnosed with cystic fibrosis. Lancet 2001;358:1964-1965.
42. Ranganathan SC, Bush A, Dezateux C, Carr SB, Hoo AF, Lum S, Madge S, Price J, Stroobant J, Wade A, Wallis C, Wyatt H, Stocks J. Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis. Am J Respir Crit Care Med 2002;166:1350-1357.